JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.62 Billion ≈ $39.19 Million USD) by net assets (Rs38.06 Billion ≈ $411.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
JB Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) financial obligations for a breakdown of total debt and financial obligations.
JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Changshu Rural Commercial Bank Co Ltd
SHG:601128
|
0.065x |
|
Chunghwa Precision Test Tech Co Ltd
TWO:6510
|
0.053x |
|
IGO LTD SP.ADR/2
F:IDZ1
|
N/A |
|
NCsoft Corp
KO:036570
|
0.009x |
|
iRay Technology Co Ltd
SHG:688301
|
0.057x |
|
Endurance Technologies Limited
NSE:ENDURANCE
|
0.105x |
|
Gibson Energy Inc.
TO:GEI
|
0.171x |
|
Centrus Energy Corp.
NYSE MKT:LEU
|
-0.063x |
Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see market value of JB Chemicals & Pharmaceuticals Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs34.33 Billion ≈ $371.30 Million |
Rs9.02 Billion ≈ $97.60 Million |
0.263x | -4.02% |
| 2024-03-31 | Rs29.23 Billion ≈ $316.15 Million |
Rs8.01 Billion ≈ $86.58 Million |
0.274x | +8.58% |
| 2023-03-31 | Rs24.80 Billion ≈ $268.24 Million |
Rs6.26 Billion ≈ $67.66 Million |
0.252x | +217.05% |
| 2022-03-31 | Rs21.39 Billion ≈ $231.28 Million |
Rs1.70 Billion ≈ $18.40 Million |
0.080x | -54.17% |
| 2021-03-31 | Rs18.13 Billion ≈ $196.12 Million |
Rs3.15 Billion ≈ $34.04 Million |
0.174x | -9.35% |
| 2020-03-31 | Rs14.38 Billion ≈ $155.51 Million |
Rs2.75 Billion ≈ $29.78 Million |
0.191x | +47.08% |
| 2019-03-31 | Rs14.83 Billion ≈ $160.37 Million |
Rs1.93 Billion ≈ $20.88 Million |
0.130x | +52.83% |
| 2018-03-31 | Rs14.44 Billion ≈ $156.20 Million |
Rs1.23 Billion ≈ $13.31 Million |
0.085x | -41.88% |
| 2017-03-31 | Rs13.66 Billion ≈ $147.71 Million |
Rs2.00 Billion ≈ $21.65 Million |
0.147x | +14.95% |
| 2016-03-31 | Rs10.95 Billion ≈ $118.46 Million |
Rs1.40 Billion ≈ $15.10 Million |
0.128x | +0.15% |
| 2015-03-31 | Rs9.95 Billion ≈ $107.59 Million |
Rs1.27 Billion ≈ $13.70 Million |
0.127x | +1049.86% |
| 2014-03-31 | Rs10.43 Billion ≈ $112.78 Million |
Rs-139.78 Million ≈ $-1.51 Million |
-0.013x | -116.10% |
| 2013-03-31 | Rs10.20 Billion ≈ $110.34 Million |
Rs849.32 Million ≈ $9.19 Million |
0.083x | -90.82% |
| 2012-03-31 | Rs9.70 Billion ≈ $104.90 Million |
Rs8.80 Billion ≈ $95.14 Million |
0.907x | +368.67% |
| 2011-03-31 | Rs6.92 Billion ≈ $74.79 Million |
Rs1.34 Billion ≈ $14.47 Million |
0.194x | -9.87% |
| 2010-03-31 | Rs5.68 Billion ≈ $61.44 Million |
Rs1.22 Billion ≈ $13.19 Million |
0.215x | +10.50% |
| 2009-03-31 | Rs4.69 Billion ≈ $50.71 Million |
Rs911.05 Million ≈ $9.85 Million |
0.194x | +210.91% |
| 2008-03-31 | Rs4.53 Billion ≈ $48.99 Million |
Rs283.11 Million ≈ $3.06 Million |
0.062x | +17.36% |
| 2007-03-31 | Rs4.18 Billion ≈ $45.26 Million |
Rs222.82 Million ≈ $2.41 Million |
0.053x | -21.99% |
| 2006-03-31 | Rs3.30 Billion ≈ $35.73 Million |
Rs225.51 Million ≈ $2.44 Million |
0.068x | -- |
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage … Read more